140 related articles for article (PubMed ID: 28429103)
1. Resolution of Primary Immune Defect in 22q11.2 Deletion Syndrome.
Suksawat Y; Sathienkijkanchai A; Veskitkul J; Jirapongsananuruk O; Visitsunthorn N; Vichyanond P; Pacharn P
J Clin Immunol; 2017 May; 37(4):375-382. PubMed ID: 28429103
[TBL] [Abstract][Full Text] [Related]
2. [Live Vaccine in Children with DiGeorge/22q11.2 Deletion Syndrome].
Miranda M; Martins AT; Carvalho S; Serra-Caetano A; Esteves I; Marques JG
Acta Med Port; 2019 Aug; 32(7-8):514-519. PubMed ID: 31445531
[TBL] [Abstract][Full Text] [Related]
3. The Immune Phenotype of Patients with CHARGE Syndrome.
Hsu P; Ma A; Barnes EH; Wilson M; Hoefsloot LH; Rinne T; Munns C; Williams G; Wong M; Mehr S
J Allergy Clin Immunol Pract; 2016; 4(1):96-103.e2. PubMed ID: 26563674
[TBL] [Abstract][Full Text] [Related]
4. Clinical characteristics and immunological status of patients with 22q11.2 deletion syndrome in Northern Thailand.
Ua-Areechit T; Varnado P; Tengsujaritkul M; Louthrenoo O; Pongprot Y; Lao-Araya M
Asian Pac J Allergy Immunol; 2023 Mar; 41(1):89-95. PubMed ID: 32416666
[TBL] [Abstract][Full Text] [Related]
5. Selective IgM deficiency and 22q11.2 deletion syndrome.
Kung SJ; Gripp KW; Stephan MJ; Fairchok MP; McGeady SJ
Ann Allergy Asthma Immunol; 2007 Jul; 99(1):87-92. PubMed ID: 17650836
[TBL] [Abstract][Full Text] [Related]
6. Improving the Diagnosis of Children with 22q11.2 Deletion Syndrome: A Single-center Experience from Serbia.
Cuturilo G; Drakulic D; Jovanovic I; Krstic A; Djukic M; Skoric D; Mijovic M; Stefanovic I; Milivojevic M; Stevanovic M
Indian Pediatr; 2016 Sep; 53(9):786-789. PubMed ID: 27771646
[TBL] [Abstract][Full Text] [Related]
7. [Clinical features and molecular diagnosis of three patients with DiGeorge anomaly].
Sun JQ; Wang LS; Qi CH; Ying WJ; Guo XH; Liu DR; Hui XY; Liu F; Cao Y; Luo FH; Wang XC
Zhonghua Er Ke Za Zhi; 2012 Dec; 50(12):944-7. PubMed ID: 23324155
[TBL] [Abstract][Full Text] [Related]
8. Persistent low thymic activity and non-cardiac mortality in children with chromosome 22q11.2 microdeletion and partial DiGeorge syndrome.
Eberle P; Berger C; Junge S; Dougoud S; Büchel EV; Riegel M; Schinzel A; Seger R; Güngör T
Clin Exp Immunol; 2009 Feb; 155(2):189-98. PubMed ID: 19040613
[TBL] [Abstract][Full Text] [Related]
9. Antibody deficiency and autoimmunity in 22q11.2 deletion syndrome.
Gennery AR; Barge D; O'Sullivan JJ; Flood TJ; Abinun M; Cant AJ
Arch Dis Child; 2002 Jun; 86(6):422-5. PubMed ID: 12023174
[TBL] [Abstract][Full Text] [Related]
10. Flow cytometric analysis of TCR Vβ repertoire in patients with 22q11.2 deletion syndrome.
McLean-Tooke A; Barge D; Spickett GP; Gennery AR
Scand J Immunol; 2011 Jun; 73(6):577-85. PubMed ID: 21323691
[TBL] [Abstract][Full Text] [Related]
11. 22q11.2 deletion syndrome: 20 years of experience from two pediatric immunology units and review of clues for diagnosis and disease management.
Ozen S; Akcal O; Taskirdi I; Haci IA; Karaca NE; Gulez N; Aksu G; Genel F; Kutukculer N
Allergol Immunopathol (Madr); 2021; 49(1):95-100. PubMed ID: 33528935
[TBL] [Abstract][Full Text] [Related]
12. FISH investigation of 22q11.2 deletion in patients with immunodeficiency and/or cardiac abnormalities.
Yakut T; Kilic SS; Cil E; Yapici E; Egeli U
Pediatr Surg Int; 2006 Apr; 22(4):380-3. PubMed ID: 16463032
[TBL] [Abstract][Full Text] [Related]
13. Immunologic features of chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome).
Jawad AF; McDonald-Mcginn DM; Zackai E; Sullivan KE
J Pediatr; 2001 Nov; 139(5):715-23. PubMed ID: 11713452
[TBL] [Abstract][Full Text] [Related]
14. Clinical and Immunological Defects and Outcomes in Patients with Chromosome 22q11.2 Deletion Syndrome.
Yu HH; Chien YH; Lu MY; Hu YC; Lee JH; Wang LC; Lin YT; Yang YH; Chiang BL
J Clin Immunol; 2022 Nov; 42(8):1721-1729. PubMed ID: 35925483
[TBL] [Abstract][Full Text] [Related]
15. Detection of 22q11.2 deletion among 139 patients with Di George/Velocardiofacial syndrome features.
Kitsiou-Tzeli S; Kolialexi A; Fryssira H; Galla-Voumvouraki A; Salavoura K; Kanariou M; Tsangaris GT; Kanavakis E; Mavrou A
In Vivo; 2004; 18(5):603-8. PubMed ID: 15523900
[TBL] [Abstract][Full Text] [Related]
16. Maturational alterations of peripheral T cell subsets and cytokine gene expression in 22q11.2 deletion syndrome.
Kanaya Y; Ohga S; Ikeda K; Furuno K; Ohno T; Takada H; Kinukawa N; Hara T
Clin Exp Immunol; 2006 Apr; 144(1):85-93. PubMed ID: 16542369
[TBL] [Abstract][Full Text] [Related]
17. DiGeorge sequence with hypogammaglobulinemia: a case report.
Chien YH; Yang YH; Chu SY; Hwu WL; Kuo PL; Chiang BL
J Microbiol Immunol Infect; 2002 Sep; 35(3):187-90. PubMed ID: 12380793
[TBL] [Abstract][Full Text] [Related]
18. Low thymic output, peripheral homeostasis deregulation, and hastened regulatory T cells differentiation in children with 22q11.2 deletion syndrome.
Ferrando-Martínez S; Lorente R; Gurbindo D; De José MI; Leal M; Muñoz-Fernández MA; Correa-Rocha R
J Pediatr; 2014 Apr; 164(4):882-9. PubMed ID: 24461789
[TBL] [Abstract][Full Text] [Related]
19. Distinct immune trajectories in patients with chromosome 22q11.2 deletion syndrome and immune-mediated diseases.
Crowley TB; Campbell IM; Liebling EJ; Lambert MP; Levitt Katz LE; Heimall J; Bailey A; McGinn DE; McDonald McGinn DM; Sullivan KE
J Allergy Clin Immunol; 2022 Jan; 149(1):445-450. PubMed ID: 34144109
[TBL] [Abstract][Full Text] [Related]
20. DiGeorge anomaly: a comparative study of the clinical and immunologic characteristics of patients positive and negative by fluorescence in situ hybridization.
Kornfeld SJ; Zeffren B; Christodoulou CS; Day NK; Cawkwell G; Good RA
J Allergy Clin Immunol; 2000 May; 105(5):983-7. PubMed ID: 10808180
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
